Point Mutation Specific Antibodies in B-Cell and T-Cell Lymphomas and Leukemias: Targeting IDH2, KRAS, BRAF and Other Biomarkers RHOA, IRF8, MYD88, ID3, NRAS, SF3B1 and EZH2

por Singh, Kunwar, Gollapudi, Sumanth, Mittal, Sasha, Small, Corinn, Kumar, Jyoti, Ohgami, Robert S.
Publicado 2021